Regeneron Hits Rival With Patent Suit Over Eye Med Generic
Regeneron accused a South Korea-based rival of infringing a slew of patents covering the American biotech company's top eye medication in a new lawsuit filed in West Virginia, claiming that its...To view the full article, register now.
Already a subscriber? Click here to view full article